Vanguard Group Inc Bio Cardia, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Bio Cardia, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 650,763 shares of BCDA stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
650,763
Previous 650,763
-0.0%
Holding current value
$1.91 Million
Previous $429,000
38.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BCDA
# of Institutions
24Shares Held
1.95MCall Options Held
17.2KPut Options Held
0-
Cm Management, LLC700KShares$2.06 Million0.25% of portfolio
-
Geode Capital Management, LLC Boston, MA156KShares$458,2250.0% of portfolio
-
Two Sigma Securities, LLC New York, NY111KShares$326,5720.0% of portfolio
-
Family Management Corp New York, NY77.5KShares$227,8500.01% of portfolio
-
Black Rock Inc. New York, NY45.9KShares$134,9190.0% of portfolio
About BioCardia, Inc.
- Ticker BCDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,758,200
- Market Cap $52.2M
- Description
- BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...